TABLE 3.
Averaged 3D gamma passing rates (%GP) and mean WET for cCBCT and vCT at different treatment sites. The better of the two algorithms are highlighted in bold font.
HN | Lung | Prostate | |
---|---|---|---|
%GP (1%/1 mm), cCBCT | 95.4% ± 2.3% | 91.7% ± 4.3% | 97.9% ± 1.4% |
%GP (1%/1 mm), vCT | 93.9% ± 1.5% | 94.6% ± 4.3% | 98.3% ± 1.0% |
%GP (2%/2 mm), cCBCT | 98.6% ± 0.9% | 97.5% ± 1.8% | 99.4% ± 0.6% |
%GP (2%/2 mm), vCT | 97.8% ± 0.7% | 98.1% ± 2.0% | 99.5% ± 0.4% |
WETdQACT (mm) | 44.8 ± 19.0 | 85.9 ± 22.5 | 166.1 ± 12.2 |
∆WETcCBCTa (mm) | 0.1 ± 0.4 | 0.0 ± 0.4 | 0.3 ± 1.1 |
∆WETvCTb (mm) | 0.5 ± 0.6 | 0.7 ± 0.5 | 1.7 ± 1.4 |
p-value (∆WET) | p = 0.02 | p = 0.18 | p = 0.0002 |
WETcCBCT-WETdQACT.
WETvCT-WETdQACT.